Startseite A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1

  • Zelal Ekinci EMAIL logo , Mehmet Baha Aytac und Hae Il Cheong
Veröffentlicht/Copyright: 29. Juni 2013

Abstract

Systemic pseudohypoaldosteronism type 1 (PHA1) is characterized by excessive salt loss from the renal tubulus, colon, sweat and salivary glands. Here we present a case of systemic PHA1 whose genetic analysis revealed a homozygous splicing mutation in intron 4 of SCNN1A (c.684+2 T>A) and discuss with the patient’s phenotype. Previously described systemic PHA cases show varying degrees of severity dependent on the mutation. Most of the SCNN1A gene mutations present with a severe phenotype. The long-term follow-up and phenotype of the two reported cases with splicing mutation of the SCNN1A gene are unknown. Our case, with a new splicing mutation of SCNN1A, presented with a severe phenotype in the neonatal period. Since then she has been well without any hospitalization and respiratory illness. Her requirement for medication also decreased gradually. After early infancy she presented a mild systemic PHA1 phenotype up to the age of 39 months. In conclusion, the mutation in the patient is located at the splicing site and is definitely a new and pathogenic one, and the phenotype of the patient was milder as observed in a patient with missense mutation.


Corresponding author: Zelal Ekinci, Department of Pediatric Nephrology, Kocaeli University Hospital, 41380 Umuttepe, Kocaeli, Turkey, Phone: +90 262 303 7227, Fax: +90 216 416 40 55, E-mail: ;

This study was supported by a grant of the Korean Health Technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A120017).

References

1. Kuhnle U. Pseudohypoaldosteronism: mutation found, problem solved? Mol Cell Endocrinol 1997;133:77–80.10.1016/S0303-7207(97)00149-4Suche in Google Scholar

2. Hanukoglu A. Type I pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 1991;73:936–44.10.1210/jcem-73-5-936Suche in Google Scholar PubMed

3. Geller DS, Zhang J, Zennaro MC, Vallo-Boado A, Rodriguez-Soriano J, et al. Autosomal dominant pseudohypoaldosteronism type 1: mechanisms, evidence for neonatal lethality, and phenotypic expression in adults. J Am Soc Nephrol 2006;17:1429–36.10.1681/ASN.2005111188Suche in Google Scholar PubMed

4. Riepe FG. Clinical and molecular features of type 1 pseudohypoaldosteronism. Horm Res 2009;72:1–9.10.1159/000224334Suche in Google Scholar PubMed

5. Zennaro MC, Hubert EL, Fernandes-Rosa FL. Aldosterone resistance: structural and functional considerations and new perspectives. Mol Cell Endocrinol 2012;350:206–15.10.1016/j.mce.2011.04.023Suche in Google Scholar PubMed

6. The Human Gene Mutation Database at the Institute of Medical Genetics in Cardiff. http://www.hgmd.cf.ac.uk.Suche in Google Scholar

7. Kerem E, Bistritzer T, Hanukoglu A, Hofmann T, Zhou Z, et al. Pulmonary epithelial sodium-channel dysfunction and excess airway liquid in pseudohypoaldosteronism. N Engl J Med 1999;341:156–62.10.1056/NEJM199907153410304Suche in Google Scholar PubMed

8. Azad AK, Rauh R, Vermeulen F, Jaspers M, Korbmacher J, et al. Mutations in the amiloride-sensitive epithelial sodium channel in patients with cystic fibrosis-like disease. Hum Mutat 2009;30:1093–103.10.1002/humu.21011Suche in Google Scholar PubMed

9. Bonny O, Knoers N, Monnens L, Rossier BC. A novel mutation of the epithelial Na+ channel causes type 1 pseudohypoaldosteronism. Pediatr Nephrol 2002;17:804–8.10.1007/s00467-002-0945-8Suche in Google Scholar PubMed

10. Edelheit O, Hanukoglu I, Gizewska M, Kandemir N, Tenenbaum-Rakover Y, et al. Novel mutations in epithelial sodium channel (ENaC) subunit genes and phenotypic expression of multisystem pseudohypoaldosteronism. Clin Endocrinol (Oxf) 2005;62:547–53.10.1111/j.1365-2265.2005.02255.xSuche in Google Scholar PubMed

11. Chang SS, Grunder S, Hanukoglu A, Rösler A, Mathew PM, et al. Mutations in subunits of the epithelial sodium channel cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type 1. Nat Genet 1996;12:248–53.10.1038/ng0396-248Suche in Google Scholar PubMed

12. Schaedel C, Marthinsen L, Kristoffersson AC, Kornfält R, Nilsson KO, et al. Lung symptoms in pseudohypoaldosteronism type 1 are associated with deficiency of the alpha-subunit of the epithelial sodium channel. J Pediatr 1999;135:739–45.10.1016/S0022-3476(99)70094-6Suche in Google Scholar

13. Saxena A, Hanukoglu I, Saxena D, Thompson RJ, Gardiner RM, et al. Novel mutations responsible for autosomal recessive multisystem pseudohypoaldosteronism and sequence variants in epithelial sodium channel alpha-, beta-, and gamma-subunit genes. J Clin Endocrinol Metab 2002;87:3344–50.10.1210/jcem.87.7.8674Suche in Google Scholar PubMed

14. Mora-Lopez F, Bernal-Quiros M, Lechuga-Sancho AM, Lechuga-Campoy JL, Hernandez-Trujillo N, et al. Novel mutation in the epithelial sodium channel causing type I pseudohypoaldosteronism in a patient misdiagnosed with cystic fibrosis. Eur J Pediatr 2012;171:997–1000.10.1007/s00431-012-1697-5Suche in Google Scholar PubMed

15. Güran T, Değirmenci S, Bulut İK, Say A, Riepe FG, et al. Critical points in the management of pseudohypoaldosteronism type 1. J Clin Res Pediatr Endocrinol 2011;3:98–100.10.4274/jcrpe.v3i2.20Suche in Google Scholar PubMed PubMed Central

16. Silva N, Costa M, Silva A, Sá C, Martins S, et al. A case of systemic pseudohypoaldosteronism with a novel mutation in the SCNN1A gene. Endocrinol Nutr 2013;60:33–6.10.1016/j.endonu.2012.07.002Suche in Google Scholar PubMed

17. Dirlewanger M, Huser D, Zennaro MC, Girardin E, Schild L, et al. A homozygous missense mutation in SCNN1A is responsible for a transient neonatal form of pseudohypoaldosteronism type 1. Am J Physiol Endocrinol Metab 2011;301: E467–73.10.1152/ajpendo.00066.2011Suche in Google Scholar PubMed

18. Hanukoglu A, Edelheit O, Shriki Y, Gizewska M, Dascal N, et al. Renin-aldosterone response, urinary Na/K ratio and growth in pseudohypoaldosteronism patients with mutations in epithelial sodium channel (ENaC) subunit genes. J Steroid Biochem Mol Biol 2008;111:268–74.10.1016/j.jsbmb.2008.06.013Suche in Google Scholar PubMed

19. Hanukoglu A, Hanukoglu I. Clinical improvement in patients with autosomal recessive pseudohypoaldosteronism and the necessity for salt supplementation. Clin Exp Nephrol 2010; 14:518–9.10.1007/s10157-010-0326-8Suche in Google Scholar PubMed

20. Adachi M, Asakura Y, Muroya K, Tajima T, Fujieda K, et al. Increased Na reabsorption via the Na-Cl cotransporter in autosomal recessive pseudohypoaldosteronism. Clin Exp Nephrol 2010;14:228–32.10.1007/s10157-010-0277-0Suche in Google Scholar PubMed

Received: 2013-2-7
Accepted: 2013-5-16
Published Online: 2013-06-29
Published in Print: 2013-11-01

©2013 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Review article
  4. Application of imaging modalities for evaluating neuroblastoma
  5. Images in pediatric endocrinology
  6. Lingual thyroid
  7. Original articles
  8. A levothyroxine dose recommendation for the treatment of children and adolescents with autoimmune thyroiditis induced hypothyroidism
  9. Fasting glucagon-like peptide-1 in patients with overt hyperthyroidism and euthyroid congenital hypothyroidism
  10. Perinatal complications and higher risks of offspring thyroid dysfunction in early childhood of Graves’ disease mothers with euthyroidism
  11. Clinical characteristics and management of cranial diabetes insipidus in infants
  12. Desmopressin administration in children with central diabetes insipidus: a retrospective review
  13. An electronic surveillance system for monitoring the hospital presentation of nutritional vitamin D deficiency in children in Scotland
  14. Frequency and severity of ketoacidosis at onset of autoimmune type 1 diabetes over the past decade in children referred to a tertiary paediatric care centre: potential impact of a national programme highlighted
  15. Vitamin D status is associated with early markers of cardiovascular disease in prepubertal children
  16. Evaluation of bone mineral density in children with type 1 diabetes mellitus
  17. Observational study of diabetes management in type 1 diabetic school-age children during holiday versus school days
  18. Relationship of body mass index and GAD65 antibody status on β-cell secretion at diabetes onset in African-American children
  19. Serum dipeptidyl peptidase 4 activity in children with type 1 diabetes mellitus
  20. Concomitant autoantibodies in newly diagnosed diabetic children with transient celiac serology or proven celiac disease
  21. Assessment of user-friendliness of the Norditropin FlexPro for pediatric patients treated with recombinant human growth hormone: results of an open-label user survey
  22. Cognitive impairment and gray/white matter volume abnormalities in pediatric patients with Turner syndrome presenting with various karyotypes
  23. Prevalence of metabolic syndrome among urban Indian adolescents and its relation with insulin resistance (HOMA-IR)
  24. Prevalence of metabolic syndrome in obese Chilean children and association with gene variants of the leptin-melanocortin system
  25. Evaluation of serum neopterin levels and its relationship with adipokines in pediatric obesity-related nonalcoholic fatty liver disease and healthy adolescents
  26. Could GSD type I expand the spectrum of disorders with elevated plasma chitotriosidase activity?
  27. Patient reports
  28. Treatment of hyperinsulinemic hypoglycemia because of diffuse nesidioblastosis with nifedipine after surgical therapies in a newborn
  29. Successful subcutaneous glucagon use for persistent hypoglycaemia in congenital hyperinsulinism
  30. A novel atypical presentation of insulin autoimmune syndrome (Hirata’s disease) in a child
  31. Diagnosis of septo-optic dysplasia in a neonate with hypernatremia, hypoglycemia, and persistent hypothermia
  32. Speech and language delay in two children: an unusual presentation of hyperthyroidism
  33. Lissencephaly presenting with congenital hypothyroidism
  34. PHEX gene mutation in a Chinese family with six cases of X-linked hypophosphatemic rickets
  35. Primary hyperparathyroidism as an extremely rare cause of secondary myelofibrosis in childhood
  36. A family with Camurati-Engelman disease: the role of the missense p.R218C mutation in TGFbeta1 in bones and endocrine glands
  37. A case of SCNN1A splicing mutation presenting as mild systemic pseudohypoaldosteronism type 1
  38. Central precocious puberty in a girl with Prader-Willi syndrome
  39. Type 1 diabetes mellitus in a patient with homozygous sickle cell anemia
  40. Short communication
  41. No impact of obesity susceptibility loci on weight regain after a lifestyle intervention in overweight children
  42. Letter to the Editor
  43. Reliability and validity of homeostasis model assessment for insulin resistance and β-cell dysfunction in critically ill children with hyperglycemia
Heruntergeladen am 22.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0053/html
Button zum nach oben scrollen